Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants
US News & World Report· 1 day agoNovavax’s updated COVID-19 vaccine candidate is likely to protect against circulating omicron variants, according ...
mRNA Vaccines Protect Against COVID-19 Mortality, Contrary to Misleading Posts - FactCheck.org
FactCheck.org· 2 weeks agoNumerous studies have shown the mRNA COVID-19 vaccines are safe and effective in preventing severe disease and death from COVID ...
Novavax's Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the...
Morningstar· 2 weeks agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373 ...
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 1 week agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
A debt-ceiling win for pharma
Politico· 1 week agoA big part of their relief is the deal retaining $5 billion for the funding of research into improved Covid-19 vaccines and treatments ...
"Lessons for a Pandemic" | naked capitalism
Naked Capitalism· 6 days agoLessons learned, and not, from a pandemic that isn't over.
Yahoo Web Search
- 16 results
Trending Now
COVID-19 vaccineMedical research
A COVID-19 vaccine is a vaccine intended to provide acquired immunity against COVID-19. Prior to the COVID-19 pandemic, work to develop a vaccine against the coronavirus diseases SARS and MERS had established knowledge about the structure and function of coronaviruses, which accelerated development during early 2020 of varied technology platforms for a COVID‑19 vaccine. wikipedia.org
- Access to COVID-19 Tools Accelerator (ACT Accelerator), Coalition for Epidemic Preparedness Innovations
- Inactivated virus; non-replicating viral vector; RNA-based; protein subunit; DNA-based; virus-like particle; replicating viral vector; live attenuated virus
- Vaccines authorized for emergency use or approved for full use by the FDA in the U.S.:
- Comirnaty and Pfizer-BioNTech COVID-19 Vaccine
- Moderna COVID-19 Vaccine (Spikevax)
- Johnson & Johnson COVID-19 vaccine, from Janssen Pharmaceutica (owned by Johnson & Johnson), and BIDMC
- Novavax COVID-19 Vaccine, Adjuvanted
